Transplantation of fibroblasts that overexpress matrix metalloproteinase-3 into the site of spinal cord injury in rats

Journal of Neurotrauma

Volumn 23, Issue 12, 2006, Pages 1750-1765

  Pizzi, Michael A ^a   Crowe, Maria J ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

EMMPRIN; MMP 3; Spinal cord injury

Indexed keywords

ADENOVIRUS VECTOR; CD147 ANTIGEN; GROWTH INHIBITOR; PROTEOCHONDROITIN SULFATE; STROMELYSIN; TACROLIMUS;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN STEM; CELL LABELING; CELL LINE; CELL TRANSPLANTATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FIBROBLAST; GLIA CELL; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; LOCOMOTION; NERVE FIBER GROWTH; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; SCAR FORMATION; SEROTONINERGIC NERVE CELL; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; TUMOR CELL;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD147; FEMALE; FIBROBLASTS; GENETIC VECTORS; MATRIX METALLOPROTEINASE 3; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SPINAL CORD INJURIES; THORACIC VERTEBRAE; TRANSDUCTION, GENETIC;

EID: 33845932921     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.23.1750     Document Type: Article

References (81)

1. ALLEN, A.R. (1911). Surgery of experimental lesions of spinal cord equivalent to crush injury of fracture dislocation. Preliminary report. JAMA 57, 878-880.
2. ANTHONY, D.C., MILLER, K.M., FEARN, S., et al. (1998). Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J. Neuroimmunol. 87, 62-72.
3. ANTRI, M., ORSAL, D., and BARTHE, J.Y. (2002). Locomotor recovery in the chronic spinal rat: effects of long-term treatment with a 5-HT2 agonist. Eur. J. Neurosci. 16, 467-476.
4. ANTRI, M., MOUFFLE, C., ORSAL, D., and BARTHE, J.Y. (2003). 5-HT1A receptors are involved in short- and long-term processes responsible for 5-HT-induced locomotor function recovery in chronic spinal rat. Eur. J. Neurosci. 18, 1963-1972.
5. BASSO, D.M., BEATTIE, M.S., and BRESNAHAN, J.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma 12, 1-21.
6. BASSO, D.M., BEATTIE, M.S., and BRESNAHAN, J.C. (1996). Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
7. BAVETTA, S., HAMLYN, P.J., BURNSTOCK, G., LIEBERMAN, A.R., and ANDERSON, P.N. (1999). The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: neuroprotection and local regeneration. Exp. Neurol. 158, 382-393.
8. BEGGAH, A.T., DOURS-ZIMMERMANN, M.T., BARRAS, F.M., BROSIUS, A., ZIMMERMANN, D.R., and ZURN, A.D. (2005). Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone. Neuroscience 133, 749-762.
9. BISWAS, C., and NUGENT, M.A. (1987). Membrane association of collagenase stimulatory factor(s) from B-16 melanoma cells. J. Cell. Biochem. 35, 247-258.
10. BRADBURY, E.J., MOON, L.D., POPAT, R.J., et al. (2002). Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416, 636-640.
11. CHERNOFF, E.A., O'HARA, C.M., BAUERLE, D., and BOWLING, M. (2000). Matrix metalloproteinase production in regenerating axolotl spinal cord. Wound Repair Regen. 8, 282-291.
12. DAVIES, S.J., FITCH, M.T., MEMBERG, S.P., HALL, A.K., RAISMAN, G., and SILVER, J. (1997). Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390, 680-683.
13. DECASTRO, R., ZHANG, Y., GUO, H., et al. (1996). Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer. J. Invest. Dermatol. 106, 1260-1265.
14. DECLERCK, Y.A. (2000). Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur. J. Cancer 36, 1258-1268.
15. FIDLER, P.S., SCHUETTE, K., ASHER, R.A., et al. (1999). Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J. Neurosci. 19, 8778-8788.
16. FOWLKES, J.L., and WINKLER, M.K. (2002). Exploring the interface between metallo-proteinase activity and growth factor and cytokine bioavailability. Cytokine Growth Factor Rev. 13, 277-287.
17. GABISON, E.E., HOANG-XUAN, T., MAUVIEL, A., and MENASHI, S. (2005). EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 87, 361-368.
18. GRIMPE, B., and SILVER, J. (2002). The extracellular matrix in axon regeneration. Prog. Brain Res. 137, 333-349.
19. GRUNER, J.A. (1992). A monitored contusion model of spinal cord injury in the rat. J. Neurotrauma 9, 123-128.
20. GUO, H., ZUCKER, S., GORDON, M.K., TOOLE, B.P., and BISWAS, C. (1997). Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J. Biol. Chem. 272, 24-27.
21. HYNDS, D.L., and SNOW, D.M. (1999). Neurite outgrowth inhibition by chondroitin sulfate proteoglycan: stalling/stopping exceeds turning in human neuroblastoma growth cones. Exp. Neurol. 160, 244-255.
22. HYNDS, D.L., and SNOW, D.M. (2001). Fibronectin and laminin elicit differential behaviors from SH-SY5Y growth cones contacting inhibitory chondroitin sulfate proteoglycans. J. Neurosci. Res. 66, 630-642.
23. HYNDS, D.L., and SNOW, D.M. (2002). A semi-automated image analysis method to quantify neurite preference/axon guidance on a patterned substratum. J. Neurosci. Methods 121, 53-64.
24. INATANI, M., HONJO, M., OTORI, Y., et al. (2001). Inhibitory effects of neurocan and phosphacan on neurite outgrowth from retinal ganglion cells in culture. Invest. Ophthalmol. Vis. Sci. 42, 1930-1938.
25. JACOBSON, R.D., VIRAG, I., and SKENE, J.H. (1986). A protein associated with axon growth, GAP-43, is widely distributed and developmentally regulated in rat CNS. J. Neurosci. 6, 1843-1855.
26. JOHNSON, W.E., CATERSON, B., EISENSTEIN, S.M., HYNDS, D.L., SNOW, D.M., and ROBERTS, S. (2002). Human intervertebral disc aggrecan inhibits nerve growth in vitro. Arthritis Rheum. 46, 2658-2664.
27. JONES, L.L., YAMAGUCHI, Y., STALLCUP, W.B., and TUSZYNSKI, M.H. (2002). NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci. 22, 2792-2803.
28. JONES, L.L., MARGOLIS, R.U., and TUSZYNSKI, M.H. (2003). The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp. Neurol. 182, 399-411.
29. KAFRI, T., VAN PRAAG, H., GAGE, F.H., and VERMA, I.M. (2000). Lentiviral vectors: regulated gene expression. Mol. Ther. 1, 516-521.
30. KIM, J.E., LIU, B.P., PARK, J.H., and STRITTMATTER, S.M. (2004). Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 44, 439-451.
31. KONDRAGANTI, S., MOHANAM, S., CHINTALA, S.K., et al. (2000). Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res. 60, 6851-6855.
32. KWON, B.K., OXLAND, T.R., and TETZLAFF, W. (2002). Animal models used in spinal cord regeneration research. Spine 27, 1504-1510.
33. LAI, C.M., LAI, Y.K., and RAKOCZY, P.E. (2002). Adenovirus and adeno-associated virus vectors. DNA Cell. Biol. 21, 895-913.
34. LEE, R., KERMANI, P., TENG, K.K., and HEMPSTEAD, B.L. (2001). Regulation of cell survival by secreted proneurotrophins. Science 294, 1945-1948.
35. LEMONS, M.L., SANDY, J.D., ANDERSON, D.K., and HOWLAND, D.R. (2003). Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord. Exp. Neurol. 184, 981-990.
36. LI, R., HUANG, L., GUO, H., and TOOLE, B.P. (2001). Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J. Cell. Physiol. 186, 371-379.
37. LIESI, P., and SILVER, J. (1988). Is astrocyte laminin involved in axon guidance in the mammalian CNS? Dev. Biol. 130, 774-785.
38. LU, J., ASHWELL, K.W., HAYEK, R., and WAITE, P. (2001). Fluororuby as a marker for detection of acute axonal injury in rat spinal cord. Brain Res. 915, 118-123.
39. MADSEN, J.R., MACDONALD, P., IRWIN, N., et al. (1998). Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154, 673-683.
40. MAJCZYNSKI, H., MALESZAK, K., CABAJ, A., and SLAWINSKA, U. (2005). Serotonin-related enhancement of recovery of hind limb motor functions in spinal rats after grafting of embryonic raphe nuclei. J. Neurotrauma 22, 590-604.
41. MARMORSTEIN, A.D., GAN, Y.C., BONILHA, V.L., FINNEMANN, S.C., CSAKY, K.G., and RODRIGUEZ-BOULAN, E. (1998). Apical polarity of N-CAM and EMMPRIN in retinal pigment epithelium resulting from suppression of basolateral signal recognition. J. Cell. Biol. 142, 697-710.
42. MATTHIESSEN, H.P., SCHMALENBACH, C., and MULLER, H.W. (1989). Astroglia-released neurite growth-inducing activity for embryonic hippocampal neurons is associated with laminin bound in a sulfated complex and free fibronectin. Glia 2, 177-188.
43. MOON, L.D., ASHER, R.A., RHODES, K.E., and FAWCETT, J.W. (2001). Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4, 465-466.
44. MORGENSTERN, D.A., ASHER, R.A., and FAWCETT, J.W. (2002). Chondroitin sulphate proteoglycans in the CNS injury response. Prog. Brain Res. 137, 313-332.
45. MUIR, E.M., ADCOCK, K.H., MORGENSTERN, D.A., et al. (2002). Matrix metalloproteases and their inhibitors are produced by overlapping populations of activated astrocytes. Brain Res. Mol. Brain Res. 100, 103-117.
46. MURAOKA, K., NABESHIMA, K., MURAYAMA, T., BISWAS, C., and KOONO, M. (1993). Enhanced expression of a tumor-cell-derived collagenase-stimulatory factor in urothelial carcinoma: its usefulness as a tumor marker for bladder cancers. Int. J. Cancer 55, 19-26.
47. NEWMAN, T.A., WOOLLEY, S.T., HUGHES, P.M., SIBSON, N.R., ANTHONY, D.C., and PERRY, V.H. (2001). T-cell- and macrophage-mediated axon damage in the absence of a CNS-specific immune response: involvement of metalloproteinases. Brain 124, 2203-2214.
48. PASTERKAMP, R.J., ANDERSON, P.N., and VERHAAGEN, J. (2001). Peripheral nerve injury fails to induce growth of lesioned ascending dorsal column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A. Eur. J. Neurosci. 13, 457-471.
49. PINNELL, S.R. (1982). Regulation of collagen synthesis. J. Invest. Dermatol. 79, Suppl 1, 73s-76s.
50. PLATT, C.I., KREKOSKI, C.A., WARD, R.V., EDWARDS, D.R., and GAVRILOVIC, J. (2003). Extracellular matrix and matrix metalloproteinases in sciatic nerve. J. Neurosci. Res. 74, 417-429.
51. POLETTE, M., GILLES, C., MARCHAND, V., et al. (1997). Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers. J. Histochem. Cytochem. 45, 703-709.
52. POWELL, E.M., and GELLER, H.M. (1999). Dissection of astrocyte-mediated cues in neuronal guidance and process extension. Glia 26, 73-83.
53. SAMESHIMA, T., NABESHIMA, K., TOOLE, B.P., et al. (2000). Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas. Int. J. Cancer 88, 21-27.
54. SARUHASHI, Y., YOUNG, W., and PERKINS, R. (1996). The recovery of 5-HT immunoreactivity in lumbosacral spinal cord and locomotor function after thoracic hemisection. Exp. Neurol. 139, 203-213.
55. SCHMALFELDT, M., BANDTLOW, C.E., DOURS-ZIMMERMANN, M.T., WINTERHALTER, K.H., and ZIMMERMANN, D.R. (2000). Brain derived versican V2 is a potent inhibitor of axonal growth. J. Cell. Sci. 113, 807-816.
56. SCHWAB, M.E., and BARTHOLDI, D. (1996). Degeneration and regeneration of axons in the lesioned spinal cord. Physiol. Rev. 76, 319-370.
57. SHAPIRO, S. (1997). Neurotransmission by neurons that use serotonin, noradrenaline, glutamate, glycine, and gamma-aminobutyric acid in the normal and injured spinal cord. Neurosurgery 40, 168-177.
58. SIDHU, S.S., MENGISTAB, A.T., TAUSCHER, A.N., LAVAIL, J., and BASBAUM, C. (2004). The microvesicle as a vehicle for EMMPRIN in tumor-stromal interactions. Oncogene 23, 956-963.
59. SILVER, J., and MILLER, J.H. (2004). Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-156.
60. SIRI, A., KNAUPER, V., VEIRANA, N., CAOCCI, F., MURPHY, G., and ZARDI, L. (1995). Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases. J. Biol. Chem. 270, 8650-8654.
61. SKENE, J.H., and WILLARD, M. (1981a). Axonally transported proteins associated with axon growth in rabbit central and peripheral nervous systems. J. Cell. Biol. 89, 96-103.
62. SKENE, J.H., and WILLARD, M. (1981b). Changes in axonally transported proteins during axon regeneration in toad retinal ganglion cells. J. Cell. Biol. 89, 86-95.
63. SNOW, D.M., SMITH, J.D., CUNNINGHAM, A.T., McFARLIN, J., and GOSHORN, B.C. (2003). Neurite elongation on chondroitin sulfate proteoglycans is characterized by axonal fasciculation. Exp. Neurol. 182, 310-321.
64. STERNLICHT, M.D., and WERB, Z. (2001). How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17, 463-516.
65. STEWARD, O., ZHENG, B., and TESSIER-LAVIGNE, M. (2003). False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J. Comp. Neurol. 459, 1-8.
66. SUN, J., and HEMLER, M.E. (2001). Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res. 61, 2276-2281.
67. SUZUKI, S., SATO, M., SENOO, H., and ISHIKAWA, K. (2004). Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP. Exp. Cell. Res. 293, 259-266.
68. TANG, Y., KESAVAN, P., NAKADA, M.T., and YAN, L. (2004). Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase- dependent generation of soluble EMMPRIN. Mol. Cancer Res. 2, 73-80.
69. TOBIAS, C.A., SHUMSKY, J.S., SHIBATA, M., et al. (2003). Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp. Neurol. 184, 97-113.
70. TOBIAS, C.A., HAN, S.S., SHUMSKY, J.S., et al. (2005). Alginate encapsulated BDNF-producing fibroblast grafts permit recovery of function after spinal cord injury in the absence of immune suppression. J. Neurotrauma 22, 138-156.
71. TOOLE, B.P. (2003). Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr. Top. Dev. Biol. 54, 371-389.
72. UGHRIN, Y.M., CHEN, Z.J., and LEVINE, J.M. (2003). Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse. J. Neurosci. 23, 175-186.
73. WESTERMARCK, J., and KAHARI, V.M. (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13, 781-792.
74. WHITELOCK, J.M., MURDOCH, A.D., IOZZO, R.V., and UNDERWOOD, P.A. (1996). The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271, 10079-10086.
75. YICK, L.W., WU, W., SO, K.F., YIP, H.K., and SHUM, D.K. (2000). Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury. Neuroreport 11, 1063-1067.
76. YONG, V.W. (2005). Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6, 931-944.
77. YONG, V.W., POWER, C., FORSYTH, P., and EDWARDS, D.R. (2001). Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2, 502-511.
78. ZHANG, Y., WINTERBOTTOM, J.K., SCHACHNER, M., LIEBERMAN, A.R., and ANDERSON, P.N. (1997). Tenascin-C expression and axonal sprouting following injury to the spinal dorsal columns in the adult rat. J. Neurosci. Res. 49, 433-450.
79. ZHOU, X.F., SONG, X.Y., ZHONG, J.H., BARATI, S., ZHOU, F.H., and JOHNSON, S.M. (2004). Distribution and localization of pro-brain-derived neurotrophic factor-like immunoreactivity in the peripheral and central nervous system of the adult rat. J. Neurochem. 91, 704-715.
80. ZUO, J., FERGUSON, T.A., HERNANDEZ, Y.J., STETLER-STEVENSON, W.G., and MUIR, D. (1998a). Neuronal matrix metalloproteinase-2 degrades and inactivates a neurite-inhibiting chondroitin sulfate proteoglycan. J. Neurosci. 18, 5203-5211.
81. ZUO, J., HERNANDEZ, Y.J., and MUIR, D. (1998b). Chondroitin sulfate proteoglycan with neurite-inhibiting activity is up-regulated following peripheral nerve injury. J. Neurobiol. 34, 41-54.